Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "unique pharmaceutical laboratories"

Commonwealth Laboratories, Inc. Announces Agreement with Valea...

SALEM, Mass.--( BUSINESS WIRE )-- Commonwealth Laboratories, Inc. (Commonwealth) announced today that it has reached an agreement with Valeant Pharmaceuticals International, Inc. (Valeant) for the acquisition by Valeant of ... Business Wire, 1 week ago
[x]  

Marksans Pharma buys out US-based Time-Cap Laboratories

Drug maker Marksans Pharma today acquired US-based Time-Cap Laboratories for an undisclosed amount. The acquisition was done through its wholly-owned subsidiary, Marksans Pharma. With this move, the company is strategically increasing its presence in the US ...
 The Financial Chronicle1 month ago

VALEANT PHARMACEUTICALS INTL : Commonwealth Laboratories Enters Agreement with Valeant Pharmaceuticals

Commonwealth Laboratories reported that it has reached an agreement with Valeant Pharmaceuticals International ("Valeant") for the acquisition by Valeant of Commonwealth's business in the United States (U.S.) and Canada . In a release, the ...
 4 Traders5 days ago
Andhra News

Colorcon Continues Investment in China – Helping Accelerate Pharmaceutical Formulation Development

Business Wire IndiaColorcon officially opened a new technical service laboratory in Beijing, China on June 25, 2015. Located in the Beijing YiZhuang Biomedical Park, this technical centre is in a unique position to work closely with the pharmaceutical ...
 Andhra News1 month ago
Citybizlist

Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations

WILMINGTON, Mass.--( BUSINESS WIRE )--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2015. For the quarter, revenue from continuing operations was $339.6 million, a ...
 Business Wire3 days ago Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement  Business Wire3 days ago Charles River Completes The Acquisition Of Celsis  BioSpace6 days ago CHARLES RIVER LABORATORIES : Announces Second-Quarter 2015 Results from Continuing Operations  4 Traders3 days ago
[x]  
Livemint.com

China Races to Find Its First Blockbuster Drug

In his quest to create the first original, billion-dollar drug from a Chinese laboratory, Chen Li is zeroing in on one of the world's fastest-growing patient groups: diabetes sufferers in China. There were 114 million of them at last count , more ...
 Yahoo! Finance2 days ago Sea Turtle Scientist Hunts for Diabetes Blockbuster in China  La Repubblica2 days ago 'Sea Turtle' Scientist Hunts for China's First Blockbuster Drug  Bloomberg2 days ago Sea Turtle scientist hunts for China's first blockbuster diabetes drug  Livemint.com2 days ago

Pfizer expands lease agreement with Massachusetts Institute of Technology

Pfizer Inc., an American pharmaceutical corporation, has announced the expansion of its lease agreement with a subsidiary of Massachusetts Institute of Technology, creating a unified Pfizer campus in Kendall Square, or KSQ. With this expansion, ...
 Individual.com2 days ago

Ligand Enters into Commercial License and Supply Agreement with Sanofi for Captisol-enabled SAR-125844

SAN DIEGO--( BUSINESS WIRE )-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a global license and supply agreement with Sanofi to utilize Captisol in the development and commercialization of ...
 Business Wire3 days ago Ligand (LGND) Enters Into Commercial License And Supply Agreement With Sanofi (SNY) For Captisol-Enabled SAR-125844 7/30/2015  ClinicSpace3 days ago LIGAND PHARMACEUTICALS : Enters into Commercial License and Supply Agreement with Sanofi for Captisol-enabled SAR-125844  4 Traders3 days ago
[x]  
TeleTrader.com

Inking a deal for immuno-oncology

PARIS & TARRYTOWN, N.Y.— Sanofi has joined with Regeneron Pharmaceuticals Inc. in a global collaboration for the discovery, development and commercialization of new antibody cancer treatments in immuno-oncology. The companies will partner for the ...
 Drug Discovery News3 days ago Sanofi, Regeneron ink collaboration to develop new antibody cancer treatments in immuno-oncology field  PharmaBiz4 days ago Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients  News-Medical.Net5 days ago Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration  Ulitzer5 days ago
[x]  

Sanofi and Regeneron partner to develop new antibody cancer treatments

Sanofi has partnered with Regeneron Pharmaceuticals to discover, develop and commercialise new antibody cancer treatments in the field of immuno-oncology. Under the deal, both firms will jointly develop a programmed cell death protein 1 (PD-1) ...
 Pharmaceutical Technology5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less